Werewolf Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Werewolf Therapeutics's estimated annual revenue is currently $7.6M per year.
- Werewolf Therapeutics's estimated revenue per employee is $138,091
- Werewolf Therapeutics's total funding is $128.2M.
- Werewolf Therapeutics's current valuation is $246M. (January 2022)
Employee Data
- Werewolf Therapeutics has 55 Employees.
- Werewolf Therapeutics grew their employee count by -7% last year.
Werewolf Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO/President/Board Member | Reveal Email/Phone |
2 | VP, Clinical Development Operations | Reveal Email/Phone |
3 | VP Immunology (Immuno-Oncology) | Reveal Email/Phone |
4 | Head Clinical Pharmacology and Pharmacometrics | Reveal Email/Phone |
5 | VP Program and Portfolio Management | Reveal Email/Phone |
6 | VP, Legal | Reveal Email/Phone |
7 | Director Operations | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Senior Director, Clinical Operations | Reveal Email/Phone |
10 | Senior Director, Financial Planning and Analysis | Reveal Email/Phone |
Werewolf Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Werewolf Therapeutics?
We are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.
keywords:N/A$128.2M
Total Funding
55
Number of Employees
$7.6M
Revenue (est)
-7%
Employee Growth %
$246M
Valuation
N/A
Accelerator
Werewolf Therapeutics News
2022-04-17 - Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Given Average ...
Werewolf Therapeutics, Inc, a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the...
2022-04-06 - Jazz Pharmaceuticals and Werewolf Therapeutics Announce ...
Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the...
2022-04-06 - Werewolf Therapeutics Shares Reverse Course Day After Deal With Jazz
Pharmaceuticals
Werewolf Therapeutics Inc. shares fell roughly 19% to $4.71, erasing gains made Thursday after the company said it signed a licensing...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $27M | 55 | -62% | $281.5M |
#2 | $8.4M | 55 | 6% | N/A |
#3 | $8.5M | 55 | 41% | N/A |
#4 | $6.9M | 55 | 15% | N/A |
#5 | $8.5M | 55 | 0% | N/A |